Acidosis differently modulates the inflammatory program in monocytes and macrophages

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1862, Issue 1, 2016, Pages 72-81

  Riemann, Anne ^a   Wußling, Hanna ^a   Loppnow, Harald ^a   Fu, Hang ^a   Reime, Sarah ^a   Thews, Oliver ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Acidosis; Immune cell function; Inflammation; Macrophages; Phagocytosis

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRATE; NITRITE; OSTEOPONTIN; TUMOR NECROSIS FACTOR ALPHA;

ACIDOSIS; ARTICLE; CELL FUNCTION; CELL MOTILITY; CELL PH; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MALE; MEDIATOR RELEASE; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84945567111     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.10.017     Document Type: Article

References (64)

1. Stubbs M., McSheehy P.M., Griffiths J.R., Bashford C.L. Causes and consequences of tumour acidity and implications for treatment. Mol. Med. Today 2000, 6:15-19.
2. Dong L., Li Z., Leffler N.R., Asch A.S., Chi J.T., Yang L.V. Acidosis activation of the proton-sensing GPR4 receptor stimulates vascular endothelial cell inflammatory responses revealed by transcriptome analysis. PLoS One 2013, 8. 10.1371/journal.pone.0061991.
3. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989, 49:6449-6465.
4. Lardner A. The effects of extracellular pH on immune function. J. Leukoc. Biol. 2001, 69:522-530.
5. Sims J.E., Smith D.E. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 2010, 10:89-102. 10.1038/nri2691.
6. Kamimura D., Ishihara K., Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev. Physiol. Biochem. Pharmacol. 2003, 149:1-38. 10.1007/s10254-003-0012-2.
7. Zhang Y., Yan W. M. a. Collins, F. Bednar, S. Rakshit, B.R. Zetter, et al., Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Cancer Res. 2013, 73:6359-6374. 10.1158/0008-5472.CAN-13-1558-T.
8. Clahsen T., Schaper F. Interleukin-6 acts in the fashion of a classical chemokine on monocytic cells by inducing integrin activation, cell adhesion, actin polymerization, chemotaxis, and transmigration. J. Leukoc. Biol. 2008, 84:1521-1529. 10.1189/jlb.0308178.
9. Tanaka T., Narazaki M., Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb. Perspect. Biol. 2014, 6. (a016295-a016295). 10.1101/cshperspect.a016295.
10. Bradley J.R. TNF-mediated inflammatory disease. J. Pathol. 2008, 214:149-160. 10.1002/path.2287.
11. Zelová H., Hošek J. TNF-α signalling and inflammation: interactions between old acquaintances. Inflamm. Res. 2013, 62:641-651. 10.1007/s00011-013-0633-0.
12. Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interf. Cytokine Res. 2009, 29:313-326. 10.1089/jir.2008.0027.
13. Aktan F. INOS-mediated nitric oxide production and its regulation. Life Sci. 2004, 75:639-653. 10.1016/j.lfs.2003.10.042.
14. Simmons D.L., Botting R.M., Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 2004, 56:387-437. 10.1124/pr.56.3.3.
15. Kahles F., Findeisen H.M., Bruemmer D. Osteopontin: a novel regulator at the cross roads of inflammation, obesity and diabetes. Mol. Metab. 2014, 3:384-393. 10.1016/j.molmet.2014.03.004.
16. Anborgh P.H., Mutrie J.C., Tuck A.B., Chambers A.F. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J. Cell. Mol. Med. 2010, 14:2037-2044. 10.1111/j.1582-4934.2010.01115.x.
17. Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 1980, 26:171-176. 10.1002/ijc.2910260208.
18. Ziegler-Heitbrock H.W., Thiel E., Fütterer A., Herzog V., Wirtz A., Riethmüller G. Establishment of a human cell line (mono Mac 6) with characteristics of mature monocytes. Int. J. Cancer 1988, 41:456-461.
19. Park E.K., Jung H.S., Yang H.I., Yoo M.C., Kim C., Kim K.S. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflamm. Res. 2007, 56:45-50. 10.1007/s00011-007-6115-5.
20. Loppnow H., Brade H., Dürrbaum I., Dinarello C.A., Kusumoto S., Rietschel E.T., et al. IL-1 induction-capacity of defined lipopolysaccharide partial structures. J. Immunol. 1989, 142:3229-3238. http://www.ncbi.nlm.nih.gov/pubmed/2651523 (accessed October 6, 2015).
21. Chen L., Frister A., Wang S., Ludwig A., Behr H., Pippig S., et al. Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H987-H996. 10.1152/ajpheart.01158.2008.
22. Fu H., Spieler F., Großmann J., Riemann D., Larisch M., Hiebl B., et al. Interleukin-1 potently contributes to 25-hydroxycholesterol-induced synergistic cytokine production in smooth muscle cell-monocyte interactions. Atherosclerosis 2014, 237:443-452. 10.1016/j.atherosclerosis.2014.10.002.
23. Netea M.G., Nold-Petry C.A., Nold M.F., Joosten L.A.B., Opitz B., van der Meer J.H.M., et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 2009, 113:2324-2335. 10.1182/blood-2008-03-146720.
24. Mia S. A. Warnecke, X.M. Zhang, V. Malmström, R. a. Harris, an optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-β yields a dominant immunosuppressive phenotype. Scand. J. Immunol. 2014, 79:305-314. 10.1111/sji.12162.
25. -{increment}{increment}Ct method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262.
26. Wang W., Ye L., Ye L., Li B., Gao B., Zeng Y., et al. Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway. Virus Res. 2007, 128:1-8. 10.1016/j.virusres.2007.02.007.
27. Pham T.N.Q., Brown B.L., Dobson P.R.M., Richardson V.J. Protein kinase C-eta (PKC-eta) is required for the development of inducible nitric oxide synthase (iNOS) positive phenotype in human monocytic cells. Nitric Oxide 2003, 9:123-134. 10.1016/j.niox.2003.09.006.
28. Guilliams M., van de Laar L. A hitchhiker's guide to myeloid cell subsets: practical implementation of a novel mononuclear phagocyte classification system. Front. Immunol. 2015, 6:1-12. 10.3389/fimmu.2015.00406.
29. Moreno-Fierros L., García-Hernández A.L., Ilhuicatzi-Alvarado D., Rivera-Santiago L., Torres-Martínez M., Rubio-Infante N., et al. Cry1Ac protoxin from Bacillus thuringiensis promotes macrophage activation by upregulating CD80 and CD86 and by inducing IL-6, MCP-1 and TNF-α cytokines. Int. Immunopharmacol. 2013, 17:1051-1066. 10.1016/j.intimp.2013.10.005.
30. Xiao Y.Q., Malcolm K., Worthen G.S., Gardai S., Schiemann W.P., Fadok V.A., et al. Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta. J. Biol. Chem. 2002, 277:14884-14893. 10.1074/jbc.M111718200.
31. Tang H., Amara U., Tang D., Barnes M.A., McDonald C., Nagy L.E. Synergistic interaction between C5a and NOD2 signaling in the regulation of chemokine expression in RAW 264.7 macrophages. Adv. Biosci. Biotechnol. 2013, 4:30-37. 10.4236/abb.2013.48A3004.
32. Jancic C.C., Cabrini M., Gabelloni M.L., Rodríguez Rodrigues C., Salamone G., Trevani A.S., et al. Low extracellular pH stimulates the production of IL-1β by human monocytes. Cytokine 2012, 57:258-268. 10.1016/j.cyto.2011.11.013.
33. Rey-Giraud F., Hafner M., Ries C.H. In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions. PLoS One 2012, 7. 10.1371/journal.pone.0042656.
34. Schwende H., Fitzke E., Ambs P., Dieter P. Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J. Leukoc. Biol. 1996, 59:555-561.
35. Steube K.G., Meyer C., Drexler H.G. Constitutive protein expression of monocyte chemotactic protein-1 (MCP-1) by myelomonocytic cell lines and regulation of the secretion by anti- and proinflammatory stimuli. Leuk. Res. 1999, 23:843-849.
36. Torres I.M., Patankar Y.R., Shabaneh T.B., Dolben E. D. a. Hogan, D. a. Leib, et al., Acidosis potentiates the host proinflammatory interleukin-1 response to Pseudomonas aeruginosa infection. Infect. Immun. 2014, 82:4689-4697. 10.1128/IAI.02024-14.
37. Park S.-Y., Bae D.-J., Kim M.-J., Piao M.L., Kim I.-S. Extracellular low pH modulates phosphatidylserine-dependent phagocytosis in macrophages by increasing stabilin-1 expression. J. Biol. Chem. 2012, 287:11261-11271. 10.1074/jbc.M111.310953.
38. Kong X., Tang X., Du W., Tong J., Yan Y., Zheng F., et al. Extracellular acidosis modulates the endocytosis and maturation of macrophages. Cell. Immunol. 2013, 281:44-50. 10.1016/j.cellimm.2012.12.009.
39. Li H., Yang B., Huang J., Lin Y., Xiang T., Wan J., et al. Cyclooxygenase-2 in tumor-associated macrophages promotes breast cancer cell survival by triggering a positive-feedback loop between macrophages and cancer cells. Oncotarget 2015, http://www.ncbi.nlm.nih.gov/pubmed/26359357 (accessed October 12, 2015).
40. Bowers L.W., Maximo I.X.F., Brenner A.J., Beeram M., Hursting S.D., Price R.S., et al. NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin-aromatase interactions. Cancer Res. 2014, 74:4446-4457. 10.1158/0008-5472.CAN-13-3603.
41. Li H.-J., Reinhardt F., Herschman H.R., Weinberg R.A. Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discov. 2012, 2:840-855. 10.1158/2159-8290.CD-12-0101.
42. Wang L., Zhang L.-F., Wu J., Xu S.-J., Xu Y.-Y., Li D., et al. IL-1β-mediated repression of microRNA-101 is crucial for inflammation-promoted lung tumorigenesis. Cancer Res. 2014, 74:4720-4730. 10.1158/0008-5472.CAN-14-0960.
43. Katanov C., Lerrer S., Liubomirski Y., Leider-Trejo L., Meshel T., Bar J., et al. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway. Stem Cell Res. Ther. 2015, 6:87. 10.1186/s13287-015-0080-7.
44. Hembruff S.L., Jokar I., Yang L., Cheng N. Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms. Neoplasia 2010, 12:425-433.
45. Dwyer R.M., Potter-Beirne S.M., Harrington K.A., Lowery A.J., Hennessy E., Murphy J.M., et al. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin. Cancer Res. 2007, 13:5020-5027. 10.1158/1078-0432.CCR-07-0731.
46. Baay M., Brouwer A., Pauwels P., Peeters M., Lardon F. Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clin. Dev. Immunol. 2011, 2011:565187. 10.1155/2011/565187.
47. Balkwill F. Tumour necrosis factor and cancer. Nat. Rev. Cancer 2009, 9:361-371. 10.1038/nrc2628.
48. Singh R., Shankar B.S., Sainis K.B. TGF-β1-ROS-ATM-CREB signaling axis in macrophage mediated migration of human breast cancer MCF7 cells. Cell. Signal. 2014, 26:1604-1615. 10.1016/j.cellsig.2014.03.028.
49. Mogi C., Tobo M., Tomura H., Murata N., He X., Sato K., et al. Involvement of proton-sensing TDAG8 in extracellular acidification-induced inhibition of proinflammatory cytokine production in peritoneal macrophages. J. Immunol. 2009, 182:3243-3251. 10.4049/jimmunol.0803466.
50. Dietl K., Renner K., Dettmer K., Timischl B., Eberhart K., Dorn C., et al. Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes. J. Immunol. 2010, 184:1200-1209. 10.4049/jimmunol.0902584.
51. Heming T.a., Tuazon D.M., Davé S.K., Chopra a.K., Peterson J.W., Bidani a. Post-transcriptional effects of extracellular pH on tumour necrosis factor-alpha production in RAW 246.7 and J774 A.1 cells. Clin. Sci. (Lond.) 2001, 100:259-266. 10.1042/CS20000192.
52. Riemann A., Schneider B., Ihling A., Nowak M., Sauvant C., Thews O., et al. Acidic environment leads to ROS-Induced MAPK signaling in cancer cells. PLoS One 2011, 6. 10.1371/journal.pone.0022445.
53. Riemann A., Ihling A., Thomas J., Schneider B., Thews O., Gekle M. Acidic environment activates inflammatory programs in fibroblasts via a cAMP-MAPK pathway. Biochim. Biophys. Acta 2015, 1853:299-307. 10.1016/j.bbamcr.2014.11.022.
54. Jiménez-Garcia L., Herránz S., Luque A., Hortelano S. Critical role of p38 MAPK in IL-4-induced alternative activation of peritoneal macrophages. Eur. J. Immunol. 2015, 45:273-286. 10.1002/eji.201444806.
55. Deng B., Wehling-Henricks M., Villalta S.A., Wang Y., Tidball J.G. IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J. Immunol. 2012, 189:3669-3680. 10.4049/jimmunol.1103180.
56. Saklatvala J. The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr. Opin. Pharmacol. 2004, 4:372-377. 10.1016/j.coph.2004.03.009.
57. Dean J.L., Brook M., Clark A.R., Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 1999, 274:264-269.
58. Feng G.J., Goodridge H.S., Harnett M.M., Wei X.Q. A. V Nikolaev, A.P. Higson, et al., Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: leishmania phosphoglycans subvert macr. J. Immunol. 1999, 163:6403-6412.
59. Schindler J.F., Monahan J.B., Smith W.G. P38 pathway kinases as anti-inflammatory drug targets. J. Dent. Res. 2007, 86:800-811. 10.1177/154405910708600902.
60. Wemmie J.A., Price M.P., Welsh M.J. Acid-sensing ion channels: advances, questions and therapeutic opportunities. Trends Neurosci. 2006, 29:578-586. 10.1016/j.tins.2006.06.014.
61. Tong J., Wu W.-N., Kong X., Wu P.-F., Tian L., Du W., et al. Acid-sensing ion channels contribute to the effect of acidosis on the function of dendritic cells. J. Immunol. 2011, 186:3686-3692. 10.4049/jimmunol.1001346.
62. Okajima F. Regulation of inflammation by extracellular acidification and proton-sensing GPCRs. Cell. Signal. 2013, 25:2263-2271. 10.1016/j.cellsig.2013.07.022.
63. Justus C.R., Dong L., Yang L.V. Acidic tumor microenvironment and pH-sensing G protein-coupled receptors. Front. Physiol. 2013, 4:1-9. (DEC). 10.3389/fphys.2013.00354.
64. Srivastava J., Barber D.L., Jacobson M.P. Intracellular pH sensors: design principles and functional significance. Physiology (Bethesda) 2007, 22:30-39. 10.1152/physiol.00035.2006.